期刊
PHARMACOGENOMICS
卷 21, 期 5, 页码 359-367出版社
FUTURE MEDICINE LTD
DOI: 10.2217/pgs-2019-0130
关键词
biomarker; breast cancer; circulating tumor DNA; ductal carcinoma in situ; liquid biopsy; radiogenomics
The widespread use of breast screening programs has contributed to the detection of early stage breast cancer, which is often asymptomatic. Early diagnosis is essential to avoid overtreatment and improve clinical outcomes, as early stage breast cancer is rarely life-threatening if detected quickly. Despite this, tissue biopsy remains the principle method for detecting these cancers. Liquid biopsy has been recently proposed as a promising detection method in oncology that is not only less invasive but also contributes to the early diagnosis of breast cancer. Here, we describe the clinical utility of liquid biopsy as a tool for the early detection of breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据